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Abstract
Hospital-acquired pneumonia, which includes aspiration pneumonia (AP), is a
preventable condition that is costly to all healthcare institutions (more than $17,000 to $
30,000 per episode), because insurance no longer covers the cost of hospital-acquired
harms. Each episode in the hospital setting can lead to patient complications, increased
use of antibiotics, patient mortality, as well as decreased patient survey scores. Several
factors put patients at risk of developing AP, and screening for these risk factors on
admission and implementing preventative nursing interventions can decrease the
incidence. Based on an extensive literature review, an evidence-based, clinical practice
guideline (CPG) was identified and adapted for a practice protocol on AP screening and
prevention for the nursing staff of an intermediate care unit at a rural hospital. The
AGREE II tool and Clinical Practice Guideline Manual were used to guide the evidencebased practice guideline adaptation, and the AGREE II tool was then used to evaluate the
adapted CPG. Once reduction of staff due to the pandemic is over, the CPG will be
presented to the quality and education departments and will be shared with administration
before implementation. It is anticipated that the use of a routinized AP prevention
program will improve patient outcomes as well as decrease patient mortality and
complications during hospitalizations. By increasing nurses’ ability to recognize those at
risk for developing AP and implementing preventative interventions on admission, this
nurse-driven protocol will promote positive social change by improving patient outcomes
and decreasing financial loss for the facility.
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Section 1: Nature of the Project
Introduction
Aspiration pneumonia (AP) is a common diagnosis in hospitals and nursing
homes that can be costly to treat at $17,517 to $30,526 per episode. The cost is absorbed
by the facility because Medicare does not cover preventable hospital-acquired illnesses.
AP is defined as a condition that occurs secondary to the presence of fluid, blood, saliva,
or gastric contents in the airway (Sanivarapu & Grossman, 2018). It can be associated
with high mortality rates, higher financial burden to the facility, longer hospital stays, use
of mechanical ventilation, intensive care stays, expensive antibiotics, increased laboratory
tests, as well as increased imaging studies (O’Malley et al., 2018). Expected mortality
among patients with AP are higher than that of other forms of pneumonia (Mandell &
Longo, 2019). AP can be prevented with patient risk assessment screening and
preventative strategies; AP protocols can decrease its occurrence. The word protocol is
used in this project to refer to interventions used to aid in the prevention of AP in the
hospital setting in Merriam Webster online dictionary (n.d.).
The purpose of this doctoral project was to identify and adapt an AP risk
assessment and prevention protocol for the nursing staff of an intermediate care unit
(IMCU). An anticipated outcome of the protocol was to improve patient outcomes and
quality of life for at-risk patients, thus demonstrating a positive social change. In Section
1, I explain the practice problem; the purpose; the nature of the project; and significance
to the hospital, patients, and nursing staff.
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Problem Statement
The hospital where this DNP project took place recognized the need for an
improvement in screening to identify patients at risk for AP. The hospital quality
department reported 25 cases since 2018, with the largest numbers reported in the IMCU.
Vulnerable patients at this small rural hospital in the southeastern United States needed
preventative measures. AP is a recognized complication for hospitalized patients, leading
to sepsis, lung abscess, shock, respiratory failure, and mortality (Komiya, Ishii, &
Kadota, 2015). According to the literature, AP can be the result of a central nervous
system compromise, resulting in dysphagia (Cipra, 2019). If specific interventions are
implemented to recognize and screen patients for the risk of dysphagia, AP can be
prevented. Early screening is important for AP prevention.
Patients are at high risk for the development of AP if they have one or more of the
following conditions: altered mental status, poor oral hygiene, neurologic disorders,
vomiting, gastric obstruction, drug abuse, alcoholism, seizures, general anesthesia,
dementia, and gastroesophageal disorders. Additionally, the elderly population is more
affected by the occurrence of AP than other types of pneumonias (Garin et al., 2014).
Nurses at the target hospital did not identify patients admitted to the IMCU with
diagnoses, which placed the patients at risk for AP; in addition, there was no protocol to
define AP risk factors and preventative measures. Failure to identify at-risk patients
resulted in increased hospital days when the patient developed AP (see Cipra, 2019). An
early AP risk assessment and protocol provides a tool for an initial screening and could
prevent AP. Thus, nurses will be patient advocates as they prevent AP through evidence-
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based practice interventions. By increasing nurses’ ability to recognize those at risk for
developing AP and implementing preventative interventions on admission, this nursedriven protocol will promote positive social change by improving patient outcomes and
decreasing financial loss for the facility.
Purpose Statement
Nationwide, pneumonia continues to be among the top 10 causes of death in the
elderly population (Franquet, 2017). At the target intermediate intensive care unit
(IMCU), AP was identified as a major issue. The gap in practice was the absence of a
screening tool to identify patients at risk for AP. If at-risk patients are identified early, the
incidence of AP in the unit could decrease because, upon identification, preventative
measures will be implemented. The implementation of a protocol should lead to
improved outcomes for patients and the hospital (Echevarria & Schwoebel, 2012). The
purpose of this project was to identify and adapt an appropriate evidence-based AP
screening and prevention protocol, or if none were available, to develop one.
The practice-focused question for this project was: What evidence-based clinical
practice guideline (CPG) can be adapted and validated for a practice protocol on AP
screening and prevention in a rural IMCU? The implementation of an AP prevention
protocol (APPP) has the potential to decrease the occurrence of AP in the IMCU,
improving patient outcomes and quality of life for the vulnerable patients as well as
decreasing loss of revenue for the facility (see Sakashita et al., 2014). These positive
changes should allow nurses to provide effective, quality health care and decrease the
likelihood of AP (Davoodvand, Abbaszadeh, & Ahmadi, 2016).
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Nature of the Doctoral Project
Following Walden University’s Clinical Practice Guideline Manual, I identified
the practice problem to be hospital-acquired AP (HAAP) and developed a practicedfocused question to address the problem. The next step was to conduct an in-depth
literature review to identify interventions that could hinder the development of AP in the
IMCU setting. The following databases were searched: MEDLINE, PubMed, Google
Search, and Translating research into practice (TRIP). The following keywords were
used: aspiration, AP, aspiration prevention protocols, dysphagia, AP development in the
non-ventilated patient, and complications of AP. The search yielded 358 articles. I
narrowed the search and reviewed six articles that spoke to elements of APPP by limiting
the search to AP bundles, AP protocols, and AP prevention strategies. The number of
studies that introduced CPG recommendations related to screening and prevention
numbered 3670; of these, 3 protocols were chosen based on usability at the project site
and were reviewed for inclusion in the CPG. I critically appraised the literature using the
step-by-step appraisal tool of Fineout-Overholt, Melnyk, Stillwell and Williamson (2010)
and organized the pertinent articles into a literature matrix (Appendix A). Based on the
evidence from the literature, I identified and adapted an AP screening and prevention
protocol. With the AGREE II tool, the content experts validated the content and ensured
usability (Brouwers et al., 2017). Revisions were made as needed. Due to Covid-19, I
was unable to present the protocol to administration, but I presented the APPP to the
education and quality departments. These departments will present the protocol to
administration when they are available. Through the APPP, I provided an evidence-based
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protocol for preventing HAAP in the IMCU, thus potentially improving the quality of life
for vulnerable patients and decreasing mortality. The APPP is expected to benefit the
hospital by reducing resources spent on HAAP. As the project leader, I addressed a gap
in practice by identifying and adapting an appropriate evidenced-based practice AP
protocol at the target facility.
Significance
Identified stakeholders for the APPP included the organization, patients, and staff,
It is anticipated that implementation of the APPP will decrease the incidence of AP in the
hospital setting, initially benefitting the IMCU by increasing positive patient outcomes
and decreasing the number of hospital days. Implementing a protocol for the prevention
of HAAP will be beneficial to the organization as well as the patient. Patients will be
impacted by the effects of evidenced-based care resulting in decreased complications,
improved quality of care, and decreased mortality rates (Mandell & Longo, 2019). The
organization will benefit from sustained revenue due to absence of hospital-acquired
patient complications (Peasah et al, 2013). The APPP will benefit nursing by
strengthening the advocacy role and introducing an evidence-based protocol to improve
quality of care (Mandell & Longo, 2019).
Finally, transferability of the APPP to any healthcare setting is possible due to the
risk of AP in all these settings, hospitals and long-term acute care facilities, because they
treat patients at risk for the development of AP the elements of this protocol can be used
in any facility with or without modification, based on the institutional needs and
population. Modifications may include added interventions for specific patient groups,
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such as for patients receiving tube feedings, may include checking residual, and
repositioning schedules for patients who are bedbound or have limited mobility
(Sakashita et al., 2014).
Summary
AP continues to be one of the most common forms of hospital-acquired
pneumonias among adults. The elderly population is more affected by AP than other
types of pneumonia. Fifty percent of those admitted with the diagnosis of AP present
with signs and symptoms of dysphagia. Each episode of HAAP is estimated to cost
$17,000 to over $30,000 per episode and is absorbed by the facility due to the denial of
Medicare to cover preventable hospital-acquired illnesses. The gap in practice at the
setting was the lack of a screening tool to identify patients at risk for AP. The purpose of
this doctoral project was to identify and adapt an AP risk assessment and prevention
protocol applicable for the nursing staff of the IMCU following the steps outlined in
Walden’s CPG manual. The AGREE II tool guided the evaluation of this APPP project.
The next section will provide greater detail about the project and my role.
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Section 2: Background and Context
Introduction
AP is a common preventable hospital illness disproportionately affecting the
elderly population (Garin et al., 2014). The target hospital quality department reported
that between 2018 and 2020, 25 cases of AP occurred, with the largest numbers being
reported in the IMCU. The purpose of this DNP project was to identify an appropriate
evidenced-based AP screening and prevention protocol based on recommended evidencebased APPPs following the steps outlined in Walden’s Clinical Practice Guideline
Manual, as well as guidelines in the AGREE II tool (see Brouwers et al., 2017), to
address the practice-focused question: What evidence-based CPG can be adapted and
validated for a practice protocol on AP screening and prevention in a rural IMCU? In
Section 2, I will discuss the use of the AGREE II tool, target background and context,
and the role of the DNP student as well as project team.
Concepts, Models, and Theories
Along with Walden University’s Clinical Practice Guideline Manual I used the
AGREE II (2017) tool as a guide for this scholarly project, an internationally validated
tool used to translate evidence into practice. The tool was used to assess the quality of the
developed guidelines through the evaluation of the six domains of guideline
development, scope and purpose, stakeholder involvement, rigor of development, clarity
of presentation, applicability, and editorial independence (Vanomeslaeghe et al., 2015).
Twenty-three items are addressed by the model (Brouwers et al., 2017).
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The AGREE II tool has been used successfully in numerous studies. Choi et al.
(2014) used the AGREE II tool to assess the quality of evidenced-based clinical practice
guidelines in traditional medicine in Korea; the quality of the CPG was found to
moderate. The resulting recommendations sought to incorporate standards, such as those
outlined in the AGREE II tool to the process of the CPG (Choi et al., 2014).
Vanomeslaeghe et al. (2015) used the AGREE II tool to evaluate the quality of existing
practice guidelines for nephropathy, identifying the need for pre-hydration for patients
suffering from contrast-induced acute kidney injury. Parisi et al.(2014) used the AGREE
II tool to validate the effectiveness of guidelines used for pediatric headaches and
identifying the need for additional research on the topic. Without the use of the AGREE
II tool the need for additional research would have remained unknown (Parisi et al.,
2014).
The AGREE II tool was an appropriate choice for this APPP project because it
met the goal of the APPP (to translate evidence into practice) and has been internationally
validated (Brouwer et al., 2017). By using the tool as a guide, the steps were clearly
outlined, and the content experts had specific, consistent points to evaluate encompassing
a wide range of areas. With the AGREE II tool, a quality CPG was developed that fit the
target setting and addressed the problem.
Relevance to Nursing Practice
AP is one of the most common forms of hospital-acquired pneumonias among
adults (O’Malley et al., 2018) and the most common type of pneumonia diagnosed in the
elderly population. Nationally, between 2012 to 2017, over 406,798 patients were
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hospitalized with AP (Wu, Chen, Wang, & Pinelis, 2017). AP is associated with longer
hospital stays, use of mechanical ventilation, intensive care stays, expensive antibiotics,
increased laboratory test, as well as increased imaging studies, higher financial burden,
and high mortality rates (O’Malley et al., 2018). Risk factors for AP include altered
mental status, neurologic disorders, and any condition that impairs the patient’s ability to
swallow. Nurses can assist in the prevention of AP by assessing patients upon admission
to the hospital setting and, upon identifying those at risk, initiate routine preventive
nursing/healthcare measures (Cipra, 2019). The occurrence of AP is a major medical
problem that can be prevented through simple nursing interventions (Cipra, 2019), thus
decreasing HAAP and the related high mortality rates. Clinical protocols are necessary to
provide guidance and needed direction to health professionals providing day to day care
(Barrow & Gaquoine, 2018).
AP Preventive Measures
Passaro, Harbarth, and Landelle (2016) identified preventive interventions to
deter the development of hospital-acquired pneumonia to include: hand hygiene, bed
elevation, oral care with an antiseptic solution, mobilization, diagnosis and treatment of
dysphagia, aspiration prevention, and viral infection and stress bleeding prophylaxis.
Likewise, O’Malley et al. (2018) identified techniques to assist in the prevention of AP.
Oral care was identified as a key intervention in the prevention of AP in the hospital
setting as it decreases the presence of bacteria in the mouth found in saliva and dental
plaque (Seedat & Peng 2016). Identifying those at risk for dysphagia was found to
decrease the occurrence of aspiration through diet and position modifications.
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Mobilization improves the ability to clear respiratory secretions from the respiratory track
(Seedat & Peng 2016). Advantages of these identified recommendations are already
hardwired in most facilities as standard care. Disadvantages of the identified
recommendations include the cost of nonabsorbable antibiotics and providing swabs for
facilities that do not have them readily available. Limitations include minimal studies
related to preventative interventions, recommending further studies to be performed
(Passaro et al., 2016).
Aspiration Risk Assessment
Cipra (2019) used an aspiration risk assessment protocol to screen patients at risk
for AP consisting of two consecutive steps. First, the risk assessment consisted of
identifying patients with a decreased level of consciousness, altered mental status,
confusion, dementia, history of stroke with residual effects, neurodegenerative disease,
alcohol/substance abuse, fall history, syncopal episodes prior to admit, inability to
perform self-oral care, poor oral health, those needing full assistance with meals,
presence of gastric or feeding tube, current pancreatitis, cholecystitis, peptic ulcer
disease, reflux, or tracheostomy. If the patient was found positive for one or more of the
mentioned conditions, they were considered as high risk for dysphagia. A swallowing
assessment followed the history for those at risk; specific protocol was initiated for
patients who were unable to be assessed or were intubated (Cipra, 2019; Komiya et al.
2015) also recognized the need for evaluation of swallowing functions to identify those at
risk for AP. Although it was difficult to predict the development of AP, screening
practices would assess swallowing ability by identifying the positive diagnosis of
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dysphagia, use of sedative medications, or central nervous disorders that may place one at
risk. AP risk assessments include the early implementation of preventative strategies
(Cipra, 2019) thus decreasing the risk of AP. The major disadvantage of the Cipra study
(2019) was that only patients who had a stroke were included in the study; the limitation
of the study was the lack of evidence for rigor.
The gap in practice at the target setting was the absence of a screening tool to
identify patients at risk for AP; if at risk patients are identified early the cases of AP in
the unit can be decreased by measures being implemented to deter the development of AP
thus leading to improved patient and hospital outcomes (Echevarria & Schwoebel, 2012).
Once shown effective, the protocol can be used in other acute and long-term care
facilities to aid in the prevention of AP as the risk factors and care needs would be
similar.
Local Background
The site for the APPP project was a rural hospital in the Southeastern United
States. The facility is a 175-bed for profit, acute care facility and provides service to a 5county area, a part of a larger cooperation which owns hospitals all over the country. The
facility provides obstetrics, pediatrics, cardiac catherization, lab, medical surgical,
intensive care, sleep lab, and other diagnostic radiological services along with an
accredited chest pain center. The average census of the hospital ranges between 35 and
88 patients. The focus of the APPP was the 15-bed IMCU, with an average census of 5 to
11, including direct admissions and patients who transfer from the intensive care unit.
Patients in the IMCU are at high risk for pneumonia due to diagnoses of altered mental
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status, neurologic disorders, esophageal motility disorders, protracted vomiting, gastric
obstruction, drug overdose, alcoholism, seizures, general anesthesia, head traumas,
intracranial masses, dementia, Parkinson disease, esophageal strictures, gastroesophageal
reflux disorders, tracheostomies, nasogastric tubes, and bronchoscopies (see Sanivarapu
& Gibson, 2019). Since 2018, 25 cases of AP occurred in the hospital setting, with the
higher percentage occurring in the IMCU. In 2008, Medicare discontinued payment for
various hospital-acquired illnesses, including AP (“Provider Preventable Conditions”,
2011).
The mission statement for the facility that is the focus of this APPP is to provide a
place where employees want to work, physicians want to practice, and patients choose to
come for healthcare. The vision of the facility is to create healthier communities. The
DNP APPP project supports the mission and vision by implementing a protocol that will
decrease patient harm and increase positive patient outcomes along with providing
financial stability for the hospital.
The facility serves the health care needs of five surrounding counties. Thirteen
hospitals in the state have closed due to Congress’ failure of expanding Medicaid to the
state; 80% of the remaining hospitals are operating at a loss. Hospitals no longer receive
reimbursement for the development of HAIs, to include HAAP, therefore preventive
measures are necessary to prevent financial loss (Vaz et al., 2015). The employment rate
for the county is approximately 7% with most of the area’s population depending on
Medicaid and the target health department for a large part of their health care needs. In
the rural parts of the state, approximately 26% of individuals are without private health
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insurance (Patton, 2018). Health care administrators, state representatives, and other
citizens are fighting to have the government approve the Medicaid expansion to increase
health care and improve health care outcomes for the citizens of our state. Refusal of the
Medicaid expansion results in the annual refusal of $14 million dollars to the state
(Powell, 2019). With these economic issues, financial stability for the hospital is a
necessity. By preventing AP, the hospital will be in a better financial state to continue to
function, even without the Medicaid expansion (Sakashita et al., 2014).
Role of the DNP Student
Currently, I am the hospital educator for the project site; I do not directly
supervise staff. This DNP project addressing AP was chosen due to my desire to reduce
the occurrence of AP which causes poor patient outcomes and financial loss for the
facility. Literature reviews were conducted to identify CPGs for consideration and
combining and modifying a CPG that would be appropriate for the IMCU. I completed a
literature search, reviewed and graded the literature, recommended the APPP based on
current best practices used in identified AP prevention protocols and assessment tools,
led the content experts in the process of using the AGREE II tool to evaluate the
recommended APPP, reviewed the results of the AGREE II tool with the team, and made
the recommended revisions. I presented the completed project to the project team and the
hospital’s quality department. Because of staffing changes and role expectations due to
the pandemic, I was unable to present the CPG to administration, but the quality
department is able to accept and implement new policies. I have no biases when it comes
to the protocol or overall project. Adapting nurse driven protocol can be an effective way
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to prevent the occurrence of AP in all long term and acute healthcare institutions (Passaro
et al., 2016).
Role of the Project Team
The project team consisted of a member of quality department, the unit manager
of IMCU, two residents (hospitalists who care for patients with an AP diagnosis), and me
as project leader. The manager for the IMCU was terminated before the process could be
completed. The role of the project team was to evaluate and review the APPP for
relevance and effectiveness using the AGREE II tool (AGREE II, 2017). The team and I
met for a total of 4 meetings. We met on a biweekly schedule for 60 minutes to discuss
the items in the protocol and assessment, the purpose of the APPP, as well as the AGREE
II tool evaluation performance that would take place as the last step. Meeting reminders,
agendas, and minutes were shared via emails and/or texts or phone calls. Once the
protocol was agreed upon, the team was given the AGREE II tool with a deadline of 2
weeks for AGREE II tool completion and return (see Appendix B).
Summary
In Section 2 I discussed the relevance of the AGREE II tool, the role of the
student, as well as the project team. The gap in practice at the target setting was a lack of
a screening tool to identify patients at risk for AP. The purpose of this doctoral project
was to identify and adapt an AP risk assessment and prevention protocol applicable for
the nursing staff of the IMCU. The development of HAAP increases hospital days,
decreasing patient satisfaction and outcomes along with hospital income. It is anticipated
that the implementation of the APPP will improve the quality of patient life and decrease
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mortality as well as allow the hospital to save revenue (Sakashita et al., 2014). The team
used the AGREE II tool to promote a successful routinization of the proposed protocol.
In Section 3 I discuss sources of evidence, the evidence collection and tracking methods,
participants of the project, and ethical considerations taken.
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Section 3: Collection and Analysis of Evidence
Introduction
AP continues to be one of the most common forms of avoidable nosocomial
infections in the hospital setting (Passaro et al., 2016), affecting the elderly population
more than any other type of pneumonias (Garin et al., 2014). Fifty percent of those
admitted with the diagnosis of AP present with signs and symptoms of dysphagia. The
occurrence of AP can be prevented through simple interdisciplinary interventions to
identify dysphagia and implement prevention measures for AP (Sakashita et al., 2014)).
In Section 3, I discussed sources of evidence, participants, ethical issues, procedures, and
the analysis and synthesis methods that will be used during the implementation phase of
the APPP.
Practiced-Focused Questions
Twenty-five cases of AP have occurred at the target practice setting since 2018.
AP can be prevented through simple interdisciplinary interventions to identify dysphagia
and implement prevention measures (Sakashita et al., 2014). Even though the literature
supports a pneumonia prevention protocol the target hospital did not have one for AP.
The gap in practice was the absence of a screening tool to identify patients at risk for AP.
The practice-focused question addressed in the DNP APPP was as follows: What
evidence-based CPG can be adapted and validated for a practice protocol on AP
screening and prevention in a rural IMCU? The purpose of this APPP project was to
identify and adapt an evidence-based APPP following the steps outlined in Walden’s
Clinical Practice Guideline Manual.
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Sources of Evidence
An extensive literature search was performed to find relevant articles on the
prevention of AP; 358 research studies and articles were found. I narrowed the search and
reviewed 6 articles that spoke to elements of APPP through the use bundles and
prevention strategies. From the 3670 articles that addressed CPG recommendations, three
protocols were chosen, based on usability in the project site and considered for inclusion
in the newly revised CPG. Collecting data and evidence of protocols used in other acute
and long-term care settings were beneficial in revising the protocol to fit the needs of the
target facility. The AGREE II results from the content experts’ evaluations were a second
source of evidence.
Participants
The team for the APPP consisted of two residents, who were a part of the
hospitalist program, and a member of the quality department; initially, the unit manager
was included but due to her termination, only the three were used. The instructions for
the AGREE II tool recommends two to four appraisers (with four preferred) to increase
the reliability of the assessment (Brouwers et al., 2017). The residents were chosen
because they care for all patients who are admitted to the hospital, including those at risk
for developing AP. A member of the quality team was appropriate due to her knowledge
of disease treatment and prevention and her experience creating protocols and standards
in the organization.
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Procedures
After an extensive literature review, pertinent articles were appraised using
evidence-based practice guidelines by Fineout-Overholt et al. (2010) and placed in a
literature matrix (Appendix A). The recommendations for the CPG were adapted from
the literature review with the literature providing current, peer-reviewed, evidence-based
practice guidelines used to deter AP in the hospital and acute care settings. The team
evaluated the newly developed CPG using the AGREE II tool (Appendix B) and
revisions were made based on recommendations of the panel. I was not allowed to meet
with administration, as planned, due to COVID-19 restrictions. After completion of the
DNP project and the pandemic restrictions are lifted, the quality department will present
the CPG for approval by administration, and the CPG will be implemented on the unit.
The occurrence of new cases of HAAP will be monitored for 6 months to collect further
data on the efficacy of the newly developed CPG. A follow up report will be
disseminated to the quality department and administration one week after all the
information has been collected from the implementation of the CPG for consideration of
hospital wide implementation.
Protection of Human Rights
Verbal and written agreement was obtained from the site where this APPP was
carried out, as well as approval from Walden University’s Institutional Review Board
(IRB Approval No. 04-29-20-0625353). As no patient data were collected there was no
ethical risk. The AGREE II tools contained no identifying data, thus the reviews were
anonymous. The paper copy of the tools will be kept in a locked drawer that only I have
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access to for a period of 3 years and then shredded. Electronic copies will be maintained
in a password protected file that only I have access to for the same 3-year period and then
deleted. All mention of the target facility was general, thus keeping the actual site
anonymous as well.
Analysis & Synthesis
The literature review matrix was used to organize the collected sources of
evidence used to revise the APPP. The literature was graded using guidelines from the
evidence-base practice steps identified by Fineout-Overholt et al. (2010). After the APPP
was adapted the 3 members of the team were given a copy of the newly revised APPP
and the AGREE II tool to evaluate the APPP. Once returned, I reviewed the results of the
AGREE II tool, complied the results, and revised the APPP, as necessary.
Summary
In Section 3, I identified sources of evidence for the literature review to support
the gap in practice at the target setting which was the absence of a screening tool to
identify patients at risk for AP. Search engines were used to identify the most recent
evidence-based guidelines for the prevention of AP, found to decrease the occurrence of
AP through standardized practices. There was a relationship between AP prevention and
basic nursing interventions to include oral hygiene, dietary interventions, swallowing
therapy, treatment of reflux, improvement of nutrition, and enteral tube feeding as well as
pharmacological. The tool was identified and adapted from an evidence-based literature
review following the Clinical Practice Guideline Manual and the AGREE II tool. After I
adapted the evidence-based CPG for APP, the team evaluated it for relevance and quality
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using the AGREE II tool. In Section 4, I discuss the outcomes of the project including the
findings, recommendations, strengths and limitations, and a self-assessment.
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Section 4: Findings and Recommendations
Introduction
With 25 cases of AP and no AP screening tool or protocol, the target hospital had
less than ideal patient outcomes and the facility was losing income because there is no
reimbursement for hospital-acquired diagnoses. The gap in practice was the absence of a
screening tool to identify patients at risk for AP. The purpose of the DNP APPP project
was to identify an AP risk assessment and protocol that the IMCU nursing staff could use
to answer the practice-focused question: What evidence-based CPG can be adapted and
validated for a practice protocol on AP screening and prevention in a rural IMCU?
An exhaustive literature search was completed to support the need for a CPG to
address AP and to provide effective evidence-based practices. A literature matrix
(Appendix A) was completed to organize the evidence and to rate its strength for the
implementation of an APPP (Appendix C) to deter the occurrence of AP in the hospital
setting. The AGREE II tool (2017) was used by a team of content experts to evaluate the
DNP APPP and screening tool. In Section 4, I address the findings and implications for
practice along with recommendations. Finally, I discuss the contribution of the team and
the strengths and limitations of the project.
Findings and Implication
Through the literature review, I found three CPGs for consideration, and by
combining and adapting the recommendations, I developed a CPG that would be
appropriate for the facility. Then, the team of three content experts, two residents and a
member of the quality department, evaluated the revised CPG for relevance and quality
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using the AGREE II tool (Brouwer et al., 2017). Each item of the six domains were
graded using a 7-point scale. A score of 7 represented strongly agree while a score of 1
represented strongly disagree. The panel was given 14 days to complete and return the
AGREE II tool, however, each member of the panel missed the deadline by one day. The
23 criteria of the Agree II tool were grouped in 6 domains with each domain representing
a different area of the guideline.
Domain 1 represented scope and purpose which represents the intent of the CPG,
the expected benefit, and the target population (Brouwers et al., 2017). The content
experts gave Domain 1 a score of 100% agreeing that the APPP was written clearly. The
experts commented: “The overall objective is clearly and precisely stated.” The content
experts commented: The age group is stated at 65 years of age and those who have
previous and or current diagnosis that place patients at risk.
Domain 2 addressed stakeholder involvement and focused on guideline
development, views, and preferences of the target population (Brouwers et al., 2017). The
content experts scored Domain 2 at 96%. The experts had no written comments in this
area.
Domain 3: focused on methods used for finding evidence, criteria for selecting
evidence, strengths and limitations of evidence, recommendations for additions or
deletions to the CPG, health benefits, link between recommendations and supporting
evidence, review of guidelines, and a procedure for updating guideline. The content
experts scored domain 3 at 88%.The content experts’ answers were more diverse for this
section, however, no questions or comments were noted from the team. The content
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experts gave low scores to the following items: item 7, systematic methods were used to
search for evidence, and item10, the methods for formulating the recommendations are
clearly described. When asked the reason for the low scores the content experts stated
that they did not understand the content of the items asked. Once the content was
explained the content experts agreed that all information was included in the APPP.
Domain 4 addressed the clarity of the presentation which included
recommendations, options for management, and key recommendations (Brouwers et al.,
2017). The content experts scored Domain 4 at 94%.
Domain 5 addressed the guideline facilitators and barriers, advice for
dissemination, resource implications, and the guideline for monitoring or auditing
criterial. The experts scored Domain 5 at 84%. The experts had no questions or
comments for this section. The following items received low scores, 18. The guideline
describes facilitators and barriers to its application; 19. The guideline provides advice
and/or tools on how the recommendations can be put into practice; 20. The potential
resource implications of applying the recommendations have been considered; and 21.
The guideline presents monitoring and/or auditing criteria. When I asked the reason for
the low scores, the content experts stated once more that they did not understand the
content of the items. Once the content was explained the content experts agreed that all
information was included in the APPP.
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Domain 6 addressed editorial independence by identifying the views of the
funding body as well as the guideline development. The domain received a combined
score of 100% (see Table 1).
Table 1
AGREE II Clinical Guideline Evaluation Tool Scores
Domains

Domain 1
Scope and
practice
Domain 2
Stakeholder
involvement
Domain3
Rigour of
development
Domain 4
Clarity of
presentation
Domain 5
applicability
Domain 6
Editorial
independence
Overall
assessment

MinimumMaximum
score
possible
1/7

Appraiser 1

Appraiser 2

Appraiser 3

Total Score

21/21

21/21

21/21

100%

1/7

20/21

20/21

21/21

96%

1/7

41/56

53/56

55/56

88%

1/7

21/21

20/21

19/21

94%

1/7

18/28

26/28

28/28

84%

1/7

14/24

14/14

14/14

100%

1/7

7/7

7/7

7/7

100%

Note. Threshold for guideline quality is 70% or greater.
The last section of the tool provided the team of experts an opportunity to
evaluate whether or not the guideline should be introduced into practice and they agreed
100% that the APPP CPG should be used in the IMCU setting, and eventually the entire
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hospital. The experts stated that the APPP was nicely written, well organized, and much
needed within the practice setting. The team agreed that the protocol will improve patient
outcomes and hospital revenue status by preventing the occurrence of AP. No additional
questions or suggestions were made at the time of appraisal.
Recommendations
The expert panel recommended the APPP be implemented for use by adding the
assessment and protocol to the admission assessment packet for all IMCU patients, thus
implementing the APPP assessment upon admission of all patients. If patients are found
to be at risk for AP, the APPP should be implemented in its entirety until discharge. Once
refined and mastered in the IMCU, the assessment and APPP can be added to the
admission assessment of all nursing units, with the IMCU nurses as the super users and
mentors for the other nurses. For future CPG projects, I would include a member of
informatics to assist with including the tool in the EMR and help identify the impact
related to nursing documentation.
Contribution of the Project Team
I met via Zoom with the content experts every 2 weeks for 60 minutes over a 6week period to discuss their role in the CPG process and the completion of the AGREE II
tool as the last task after the CPG was revised. Once completed, the CPG (see Appendix
C) was emailed to the experts, along with the AGREE II tool and instructions for its
completion. Also included was the meeting agenda (see Appendix D). The experts were
provided 14 days to complete and return the AGREE tool, however, each member of the
panel missed the deadline by one day. After reviewing the protocol, the team of experts
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agreed 100% that the APPP was needed in the organization. As mentioned above, once
the APPP will be introduced in the IMCU after approval from administration, and
adjustments will be made as needed, which can only be identified with use. After IMCU
has refined the CPG, it will be introduced for hospital wide adoption.
Strengths and Limitations of the Project
Strengths of the project included the ability to find a team of experts qualified and
willing to participate, and a site in which to carry out the project. The hospital frequently
cares for patients who have AP on or during their admission to the hospital and the
residents often care for these patients. An additional strength was the ability to find
current, peer reviewed information to use in the process of adapting an APPP that is
appropriate for the target setting.
Limitations of the project included the pandemic affecting the ability to carry out
the last step of the project. I was unable to present to administration; however, the quality
department will make the presentation and implement the APPP in the facility. Due to the
lack of a clinical manager for the IMCU, I was unable to have a manager from the unit on
the expert panel, however, she was only invited to join due to her managing the floor, her
absence did not affect the completion of the project. Future projects to be considered
include the development of CPG to address other chronic illnesses like diabetes or
hospital-acquired harms like pressure ulcers. The process would be the same as used in
this project, but the literature search would need to be carried out specific to the issue
being addressed. Any hospital-acquired conditions that can be minimized would improve
patient outcomes and hospital finances.
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Summary
In this Section I discussed findings and implications in regard to the APPP. The
expert panel recommended the CPG be implemented throughout the facility after it has
been refined and mastered in the IMCU. Though the restrictions due to the pandemic and
the loss of the unit manager were limitations, the strength of the evidence-based literature
and quality of the experts aided me in adapting a CPG to meet the needs of the facility.
Recommendations of the experts were identified according to results received from the
completion of the AGREE II tool by the doctoral team along with the strengths and
limitations of the project. In Section 5, I discuss the plan for dissemination as well as an
analysis of myself.
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Section 5: Dissemination Plan
The target hospital quality department reported that since 2018, 25 cases of AP
occurred, with the largest numbers being reported in the IMCU. The gap in practice was
the lack of a screening tool to identify patients at risk for AP; if at risk patients are
identified early, the cases of AP in the unit can be decreased. The APPP project answered
the question: What evidence-based CPG can be adapted and validated for a practice
protocol on AP screening and prevention in a rural IMCU? By modifying a CPG for AP
appropriate for the target setting. The final CPG was presented to the quality and education
departments and will be shared with administration before implementation once reduction of staff
due to the pandemic is over. The quality department will introduce the process to staff and

unit leaders in the facility, beginning with the IMCU. The implementation of the protocol
should lead to improved patient and hospital outcomes (Echevarria & Schwoebel, 2012).
Once implemented in the IMCU, the APPP will be implemented on the remaining
nursing units, intensive care and the second medical-surgical unit. Next, the project will
be published in ProQuest and my future plan is to have this APPP published in Medical
Surgical Nursing Journal or The American Journal of Nursing, which have robust
platforms with a diverse population of professional nurses, some of whom work in
hospital settings where AP is common. I will submit a presentation of this work for the
annual Alabama State Nurses Association FACES conference, a forum to present the
APPP to other acute care facility staff where AP is likely to be a problem to nursing
students from entry level to DNP. Educating nurses on the issue and ways to prevent AP
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will better prepare them to provide quality care and help the facilities they will work save
money.
Analysis of Self
My time as a DNP student has provided me the opportunity to grow as a
professional nurse. As a practitioner, my ability to analyze information has greatly
evolved. As a scholar, I was forced to work on my ability to write scholarly and with
purpose. Before beginning the CPG project, I was not well versed in the levels of
evidence and how they pertain to research. As a result of this journey, I feel more
comfortable with the process of implementing evidence-based research. Serving as
project manager for the APPP, I spent uncountable hours identifying protocols that could
be adapted to meet the needs of the IMCU, strengthening my practice of finding and
evaluating evidence-based literature to apply to the practice setting. The frequent
development of AP in the IMCU caused me to find measures to prevent the occurrence in
the hospital setting. It is my ultimate goal to use these newly developed skills to become
a change agent in my community and any organization that I choose to become a part of.
I plan to serve as a preceptor and mentor to others seeking to increase their knowledge
base in nursing practice, sharing my challenges and newfound skills.
There were many challenges during the process of the APPP. Initially, it was the
absence of an IMCU manager, over the course of the APPP the role was filled by three
different managers. Even though the unit manager was not a vital part of the project, her
input on how the interventions could be implemented on the unit would have been useful.
The second challenge was the development of COVID-19 which prevented me from
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presenting to administration, forcing me to change the process of dissemination. The
team member who was from the quality department will present the information to
administration once the pandemic is resolved, or at least lessened.
The third challenge was the limited number of protocols that addressed AP.
Although AP protocols were available, very few included the elements that were
appropriate for the target facility, like tube feeding interventions, performance of oral
care, and the use of an incentive spirometer. By combining parts of the various CPGs, I
was able to develop an appropriate CPG to meet the needs of the setting. The final
challenge was the failure of the content experts to return the AGREE II tool results to me
in a timely manner. The team was asked to return the results in 14 days; however, the
results were not received until Day 15. I addressed the issue on Day 14 by emailing and
texting the team asking them to submit the results as soon as possible. The team
responding by stating that they would have them to me by noon the next day. It might
have been more appropriate to send reminders throughout the 14 days. A 1-day delay was
a minor inconvenience with minor delays for me analyzing the results. Insights included
my ability to identify a problem in the target facility and perform the necessary literature
search to address it. I feel that by addressing this problem I will be able to implement
interventions to prevent the occurrence of AP at the current IMCU site and more prepared
to recognize, develop, and introduce needed changes in the facility.
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Summary
AP is a common diagnosis seen in hospitals and nursing homes that is preventable
and can be costly to treat, at over $17,000 to $30,000 per episode. This cost is absorbed
by the facility due to the denial of Medicare to cover preventable hospital-acquired
illnesses. With the numerous occurrences of AP in the IMCU at a hospital in the
Southeastern United States, I made the decision to address the issue in the organization.
Preventing the occurrence of AP is vital to the cost-effective operation of the IMCU. I
reviewed methods that would deter the occurrence of AP in acute and long-term health
care facilities and adapted a CPG appropriate for the facility where this project was
carried out. The implementation of the APPP in the facility should improve quality
healthcare and decrease the likelihood of AP, as well as allow positive patient and
hospital outcomes.
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Appendix A: Literature Review Matrix
Reference

Cipra, E. (2019). Implementation of a
risk assessment to reduce aspiration
in non-stroke patients. Clinical Nurse
Specialist, 6, 279.
doi:10.1097/NUR.000000000000048
4

Theoretical/
conceptual
framework
N/A

Research
question(s)/
hypotheses or purpose

Research
methodology

Analysis
& results

Conclusions

Grading
the
Evidence

Purpose: There was no
process in place to
identify at risk of
aspiration who did not
present with stroke
symptoms.

Descriptive

An aspiration
risk
assessment
tool and
aspiration
precaution tool
were initiated.
Results
reviewed the
closeness and
sympathy that
nurses feel for
their patients.
Preventive
measures
should be put
in place to aid
in aspiration
pneumonia
prevention.

With performance
of the screening
tool the rate of
hospital acquired
risk assessment
decreased.

Level I

Nurses develop
close relationships
with their
patients.

Level VI

Prevention is an
effective practice
to disease
prevention.

N/A

Thickened fluids
have been
identified as a
safer alternative
however, further
studies are needed
to identify why
the method is
effective

Level VI

Davoodvand, S., Abbaszadeh, A., &
Ahmadi, F. (2016). Patient advocacy
from the clinical nurses’ viewpoint:
A qualitative study. Journal of
Medical Ethics and History of
Medicine. 9(5), 1-8
Echevarria, I. M. & Schwoebel, A.
(2012). Development of an
intervention model for the prevention
of aspiration pneumonia in high-risk
patients on a medical-surgical unit.
Medical Surgical Nurse, 21(5), 303308.

N/A

Purpose: examine the
viewpoint of nurses as
patient advocates.

Qualitative study
that examined the
viewpoint of clinical
nurses as patient
advocates.

The Quality
Health
Outcomes
Model
(QHOM)

Tool development

Garin, N., DePoureq, J., MartinVenegas, R., Cardona, D., Gich, I., &
Mangues, M. (2014). Viscosity
differences between thickened
beverages suitable for elderly patients
with dysphagia. Springer Science
Media, 29, 483-488. doi:
10.1007/s00455-014-95-33x

N/A

Purpose: To describe
an intervention model
for the prevention of
aspiration pneumonia
at an urban teaching
hospital in the
northern eastern
United States.
The study was
performed to examine
the viscosity of 11
different thickened
liquids.

Descriptive
Study

Differences
were noted
between
sample groups
with the use of
two
commercial
thickeners.
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interdisciplinary quality improvement
initiative to reduce AP. Journal of
Nursing Care Quality, 33(2), 116122.
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N/A

N/A

Plan Do
Study Act

Purpose: to focus on
the definition of,
prevalence and the
role of aspiration
pneumonia as well as
methods to identify
problems associated
with the development
of aspiration
pneumonia.
The focus of this
review was to examine
the clinical features,
diagnosis, treatment,
and prevention of both
aspiration pneumonia
and chemical
pneumonitis, as well
risk factors. The
review also focused on
aspiration including
the lung parenchyma,
aspiration, and
chemical pneumonia.
Purpose: to improve
dysphagia screening
and decrease
aspiration pneumonia
in the hospital setting.

Systematic review

Study reveals a
decrease in the
occurrence of
postextubation
pneumonia.

A nurse
performed
screening is better
and safer than not
screening patients.

Level V

A review

The
occurrence of
aspiration
pneumonia
often goes
unnoticed.

Aspiration is
extremely hard to
diagnose.

Level IV

Quality
Improvement
Project

The project
was successful
in decreasing
cases of
aspiration
pneumonia.

The project was
successful,
resulting in the
process becoming
routinized in the
hospital setting.

N/A
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C. (2016). Prevention of hospitalacquired pneumonia in non-ventilated
adults: A narrative review.
Antimicrobial Resistance and
Infection Control, 2016(5), 43.
doi:10.1186/s13756-016-0150-3

N/A

Overview of standards
for the prevention of
aspiration pneumonia.

A literature review

Peasah, S., McKay, N., Harman, J.,
Al-Amin, M., & Cook, R. (2013).
Medicare non-payment of hospital
acquired infections: Infections rates
there years post implementation.
Medicare & Medicaid Research
Review, 3(3), 1-12.
doi.org/10.5600/mmrr.003.03. a08

Trend
Analysis

Hypothesis that both
individual risks and
rates of hospital
acquired catheter
associated urinary
tract infections and
vascular catheter
associated infections
will be lower after a
policy is put into
place.

This retrospective
study

Sakashita, R., Takami, M., Ono, H.,
Nishihira, T., Sato, T., & Hamada,
M. (2014). Preventing AP among the
elderly: A review focused on the
impact of the consistency of food
substances. Interface Oral Health
Science, 335-351. doi:
org/10.1007/978-4-431-55192-8_29

N/A

Impact of food
consistency with the
elderly population.

Systemic Review

Bed
positioning,
mobilization,
and preventive
measures must
all be
addressed in
an effort to
prevent
aspiration
pneumonia.
Both hospitals
acquired
catheter
associated
urinary
infections and
vascular
catheter
associated
infections
decreased after
the policy
initiation.
Interventions
have been
shown to
decrease the
incidence of
aspiration
pneumonia
among those
suffering from
stoke and other
neurological
deficits.

Further studies are
needed to identify
the best treatment
practice for
dysphagia1

Level V

Initiation of a
policy was
successful;
however, more
studies are needed
due to the
limitations of the
study.

Level IV

High quality
randomized
control trails are
needed to identify
interventions
needed for the
prevention of
aspiration
pneumonia and
prevention.

Level III
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G. (2018). Pneumonia, Aspiration.
StatPearls, 1-3.
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Retrospective Study

See, C.K., Peng, S., Phua, J., Sum,
C., & Concepcion, J. (2016). Nurseperformed screening for
postintubation dysphagia: A
retrospective cohort study in
critically ill medical patients. Critical
Care, 2016(20), 326. doi:
org/10.4102/sajcd. v63i1.102

N/A

Purpose: to identify if
nurse performed
screening
(NPS) performed at
the bedside after
extubation are safe or
effective.

Retrospective cohort
study of extubated
patients.

Wu, C. P., Chen, Y. U., Wang, M. J.,
& Pinelis, E. (2017). National trends
in admission
for AP in the United States, 20022012. Annals of the American
Thoracic Society,
14(6), 874-879.
doi.org/10.513/AnnalsATS.20161186700

N/A

Identify the incidence
and mortality rate of
aspiration pneumonia
in the United States.

U.S. National
(Nationwide)
Inpatient Sample
database was used to
identify patients at
admitted with
aspiration
pneumonia between
2002 and 2012.
Multivariable
logistic was used to
identify independent
predictors for
hospital mortality.

Aspiration
pneumonia
accounts for 515% of all
types of
community
acquired
pneumonia.
It was
determined
that the
performance
of
NPS identified
patients who
were unable to
eat safely after
extubation.
Although the
cases of AP in
the elderly
population
decreased
between 2002
to 2012 the
cost of AP
hospitalization
s have
increased.

It is difficult to
determine the true
incidence of
aspiration
pneumonia due to
the most cases
being
unwitnessed.
Nurse performed
screenings are
effective and are
more reliable than
the absence of
screening. NPS
are more cost
effective than
other methods.

Level IV

Elderly patients
who are
diagnosed with
AP have a greater
mortality rate than
the younger
population.

N/A

Level IV
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Note. Evidence graded using the hierarchy of evidence model from “Evidence-based Practice Step by Step: Critical appraisal of
the evidence: Part I,” by E. Fineout-Overholt 1, B. M. Melnyk, S. B Stillwell, and K. M Williamson, 2010, American Journal of
Nursing, 110(7), p.47-60.
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Appendix B: AGREE II Tool

DOMAIN 1. SCOPE AND PURPOSE
1.

The overall objective(s) of the guideline is (are) specifically described. (p.7)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

2.

The health question(s) covered by the guideline is (are) specifically described. (p.8)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

3.
The population (patients, public, etc.) to whom the guideline is meant to apply is specifically
described. (p. 28)
1
Strongly Disagree

Comments

2

3

4

5

6

7
Strongly Agree
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DOMAIN 2. STAKEHOLDER INVOLVEMENT

4. The guideline development group includes individuals from all relevant professional groups. (p. 11)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

5. The views and preferences of the target population (patients, public, etc.) have been sought. (p.40)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

6. The target users of the guideline are clearly defined. (p.40)
1
Strongly Disagree

Comments

2

3

4

5

6

7
Strongly Agree
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7. Systematic methods were used to search for evidence. (p.37)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

8. The criteria for selecting the evidence are clearly described. (p. 42-43)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

9. The strength and limitations of the body of evidence are clearly described. (p. 40)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

10. The methods for formulating the recommendations are clearly described. (p. 47)
1
Strongly Disagree

Comments

2

3

4

5

6

7
Strongly Agree
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11.
The health benefits, side effects, and risks have been considered in formulating the
recommendations. (p. 48)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

12.

There is an explicit link between the recommendations and the supporting evidence. (p.54)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

13.

The guideline has been externally reviewed by experts prior to its publication. (p. 11)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

14.

A procedure for updating the guideline is provided. (p 56)
1
Strongly Disagree

Comments

2

3

4

5

6

7
Strongly Agree
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15. The recommendations are specific and unambiguous. (p. 54)
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

16. The different options for management of the condition or health issue are clearly presented.
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

17. Key recommendations are easily identifiable. (p.54)
1
Strongly Disagree

Comments

2

3

4

5

6

7
Strongly Agree
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DOMAIN 6. EDITORIAL INDEPENDENCE

22. The views of the funding body have not influenced the content of the guideline.
1

2

3

4

5

6

Strongly Disagree

7
Strongly Agree

Comments

23. Competing interests of guideline development group members have been recorded and addressed.
1
Strongly Disagree

Comments

2

3

4

5

6

7
Strongly Ag
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OVERALL GUIDELINE ASSESSMENT
For each question, please choose the response which best characterizes the guideline
assessed:
1. Rate the overall quality of this guideline.

1
Lowest possible
quality

2

3

4

2. I would recommend this guideline for use.

YES
YES, With modifications
NO

NOTES

5

6

7
Highest possible
quality
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Appendix C: Clinical Practice Guideline - APPP
Procedure
•
•
•

•

The aspiration risk assessment will be performed at the bedside upon admission by the
admitting nurse.
If the patient answers yes to any of the risk assessment questions the APPP will be
initiated addressing all the identified interventions.
The AP risk assessment will be repeated if the patient has a change in status during their
hospitalization.
o Change in patient’s status refers to the following: cerebrovascular accident,
altered mental status, extubation, and or any condition that was not present on
admission.
The nurse will follow the instructions of the risk assessment and APPP.

Question
What interventions can be performed by the nurse at the bedside to best prevent the
occurrence of AP?
Population
•

•

The risk assessment and APPP will be performed on
o Patients who are 65 years of age as well those who have a previous and/or
current diagnosis that places them at risk for AP.
These risks include:
• decreased level of consciousness,
• altered mental status,
• confusion,
• dementia,
• history of stroke with residual effects,
• neurodegenerative disease,
• alcohol/substance abuse,
• Fall history,
• syncopal episodes during or prior to admit,
• inability to perform self-oral care,
• poor oral health,
• those needing full assistance with meals,
• presence of gastric or feeding tube,
• current pancreatitis,
• cholecystitis,
• peptic ulcer disease,
• reflux,
• or tracheostomy (Cipra, 2019).
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Recommendations
There is no protocol in place for AP pneumonia although literature shows the use of preventive
interventions in the deterrence of AP (O’Malley et al., 2018).
•

•

•
•
•

AP is associated with longer hospital stays, use of mechanical ventilation, intensive care
stays, expensive antibiotics, increased laboratory test as well as increased imaging
studies, higher financial burden, and high mortality rates (O’Malley et al., 2018).
Nurses can assist in the prevention of AP by assessing patients upon admission to the
hospital setting and, upon identifying those at risk, initiate preventive nursing/healthcare
measures (Cipra, 2019).
Twenty-five cases of AP have occurred at the hospital since 2018.
The occurrence of AP can be prevented through simple interdisciplinary interventions
(Sakashita et al., 2014) beginning with screening for dysphagia.
The APPP will assist nurses at the bedside in beginning preventive interventions to deter
the development of hospital acquired pneumonia.

Key Evidence
Oral care has been identified as a key intervention in the prevention of AP in the hospital
setting as it decreases the presence of bacteria in the mouth found in salvia and dental
plaque ( Seedat & Peng 2016).
• Identifying those at risk for dysphagia has been found to decrease the occurrence of
aspiration through diet and position modifications (Seedat & Peng, 2016).
• Clinical protocols are necessary to provide guidance and needed direction to health
professionals providing day to day care (Barrow & Gaquoine, 2018).
• Advantages of AP risk assessments include the early implementation of prevention
strategies thus decreasing the risk of AP (Cipra, 2019).
Guideline Monitoring
•

•

•

The guideline should be reviewed every 3 years or whenever new guidelines are
identified. .
Barriers to the application of this guideline should be addressed as they arise by the
practitioner and before implementation.
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•

Aspiration Risk Assessment
(Please answer yes or no in regard to the patients current and past conditions.)
• If one or more of the answers to the questions is yes, initiate the APPP.
Decreased Level of Consciousness
Altered Mental Status, Confusion, Dementia
History of Stroke with Residual effects (facial dropping or paralysis)
Neurodegenerative Disease (to include ALS, Parkinson’s)
ETOH/Substance Abuse (Past or Current)
Fall Immediately Prior to Admit
Syncopal Episode/Loss of Consciousness Immediately 7 days/one week Prior to Admit
Unable to Perform Self Oral Hygiene
Poor Dentition/ Poor Oral Health
Requires Help with all Meals (Other than set up)
Presence of Gastric or Feeding Tube
Current Pancreatitis, Cholecystitis, PUD and/or Reflux
Tracheostomy
None

Note. Adapted from” Implementation of a risk assessment to reduce aspiration in nonstroke patients,” by E. Cipra, 2019, Clinical Nurse Specialist, 6, p. 279.
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Aspiration Pneumonia Preventive Protocol
(Use this protocol if one or more of the questions to the aspiration assessment is “yes”.)
Place signage over the head of bed identifying patient as high risk
Elevate the HOB 30-45 degrees and have patient sit up for all meals (remaining sitting up for 1
hour after meals)
Assist with eating drinking, taking meds as needed
Assess for gag reflex
Monitor the reflux and gastric residuals (NG tube) before all feedings. If residual is greater than
60cc’s hold the scheduled feeding and notify the physician.
Early mobilization
Cough and deep breath or incentive spirometry every four hours daily while awake
Oral Care x4 daily (before meals and bedtime)
Suction set up at the bedside on admission

Note. Adapted from “Lower Respiratory Problems” by Harding, Kwong, Roberts, Hagler &
Reinisch, as cited in Mondor (2019), Lewis’s medical-surgical nursing: Assessment and
management of clinical problems. p.509.

Sources
Cipra, E. (2019). Implementation of a risk assessment to reduce aspiration in non-stroke patients.
Clinical Nurse Specialist, 6, 279. doi:1097/NUR.000000000000484.
Mondor, E. (2019). Lower respiratory problems. In Harding, M., Kwong, J., Roberts, D., Hagler,
D., & Reinisch, C. Lewis’s medical-surgical nursing: Assessment and management of
clinical problems. New Philadelphia, Ohio: Mosby
O’Malley, M. B., Trotta, R., Rohrbach, J., Ahya, V., & Bradway, C. (2018). Project SITUP an
interdisciplinary quality improvement initiative to reduce AP. Journal of Nursing Care
Quality, 33(2), 116-122. doi:10.1097/NCQ.0000000000000285
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Appendix D: Team of Expert Meeting Invitation

